Cargando…

Implementation of a vaccine against Shigatoxin 2e in a piglet producing farm with problems of Oedema disease: case study

Oedema disease is one of the major diseases in pigs during the nursery period. It is caused by Shigatoxin 2e producing strains of Escherichia coli. In order to combat the disease, the metaphylactic use of colistin sulphate and zinc oxide is widely spread. Additionally, special feeding regimens such...

Descripción completa

Detalles Bibliográficos
Autores principales: Fricke, Regine, Bastert, Olaf, Gotter, Verena, Brons, Nico, Kamp, Johan, Selbitz, Hans-Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5375124/
https://www.ncbi.nlm.nih.gov/pubmed/28405415
http://dx.doi.org/10.1186/2055-5660-1-6
_version_ 1782518982978306048
author Fricke, Regine
Bastert, Olaf
Gotter, Verena
Brons, Nico
Kamp, Johan
Selbitz, Hans-Joachim
author_facet Fricke, Regine
Bastert, Olaf
Gotter, Verena
Brons, Nico
Kamp, Johan
Selbitz, Hans-Joachim
author_sort Fricke, Regine
collection PubMed
description Oedema disease is one of the major diseases in pigs during the nursery period. It is caused by Shigatoxin 2e producing strains of Escherichia coli. In order to combat the disease, the metaphylactic use of colistin sulphate and zinc oxide is widely spread. Additionally, special feeding regimens such as the reduction of the amount of crude protein and the increase of the amount of crude fibre are applied. The goal of this study was to test the efficacy of a vaccine against Oedema disease caused by Shigatoxin 2e in a field trial on a farm with a history of Oedema disease in nursery pigs. The study was carried out on a Dutch farm with 600 sows and a one-week farrowing rhythm and lasted for the time of one year. During this time all piglets were vaccinated with 1 ml ECOPORC SHIGA at the average age of 4 days. The parameters Overall mortality, use of antimicrobials in general, calculated as defined daily dose per animal, use of colistin sulphate and the weight gain were evaluated for all nursery pigs and compared to historical data of animals from the same period of time directly prior to the study serving as a historical control group. The previous mortality in the nursery of 7.7% was significantly reduced to 1.3% after vaccination. The metaphylactic use of colistin sulphate during the nursery period was stopped during the study because no deaths due to Oedema disease had occurred anymore after beginning of vaccination. The defined daily dose per animal per month was significantly reduced from a mean of 1.050 in the year 2012 to a mean of 0.215 in the year 2013. The defined daily dose per animal per year was therefore relevantly reduced from 12.6 in 2012 to 2.6 in 2013. These results show that on this farm Oedema disease can not only be controlled successfully by vaccination but also that vaccination can significantly reduce the use of antimicrobials in the nursery period.
format Online
Article
Text
id pubmed-5375124
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53751242017-04-12 Implementation of a vaccine against Shigatoxin 2e in a piglet producing farm with problems of Oedema disease: case study Fricke, Regine Bastert, Olaf Gotter, Verena Brons, Nico Kamp, Johan Selbitz, Hans-Joachim Porcine Health Manag Case Study Oedema disease is one of the major diseases in pigs during the nursery period. It is caused by Shigatoxin 2e producing strains of Escherichia coli. In order to combat the disease, the metaphylactic use of colistin sulphate and zinc oxide is widely spread. Additionally, special feeding regimens such as the reduction of the amount of crude protein and the increase of the amount of crude fibre are applied. The goal of this study was to test the efficacy of a vaccine against Oedema disease caused by Shigatoxin 2e in a field trial on a farm with a history of Oedema disease in nursery pigs. The study was carried out on a Dutch farm with 600 sows and a one-week farrowing rhythm and lasted for the time of one year. During this time all piglets were vaccinated with 1 ml ECOPORC SHIGA at the average age of 4 days. The parameters Overall mortality, use of antimicrobials in general, calculated as defined daily dose per animal, use of colistin sulphate and the weight gain were evaluated for all nursery pigs and compared to historical data of animals from the same period of time directly prior to the study serving as a historical control group. The previous mortality in the nursery of 7.7% was significantly reduced to 1.3% after vaccination. The metaphylactic use of colistin sulphate during the nursery period was stopped during the study because no deaths due to Oedema disease had occurred anymore after beginning of vaccination. The defined daily dose per animal per month was significantly reduced from a mean of 1.050 in the year 2012 to a mean of 0.215 in the year 2013. The defined daily dose per animal per year was therefore relevantly reduced from 12.6 in 2012 to 2.6 in 2013. These results show that on this farm Oedema disease can not only be controlled successfully by vaccination but also that vaccination can significantly reduce the use of antimicrobials in the nursery period. BioMed Central 2015-05-07 /pmc/articles/PMC5375124/ /pubmed/28405415 http://dx.doi.org/10.1186/2055-5660-1-6 Text en © Fricke et al. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Study
Fricke, Regine
Bastert, Olaf
Gotter, Verena
Brons, Nico
Kamp, Johan
Selbitz, Hans-Joachim
Implementation of a vaccine against Shigatoxin 2e in a piglet producing farm with problems of Oedema disease: case study
title Implementation of a vaccine against Shigatoxin 2e in a piglet producing farm with problems of Oedema disease: case study
title_full Implementation of a vaccine against Shigatoxin 2e in a piglet producing farm with problems of Oedema disease: case study
title_fullStr Implementation of a vaccine against Shigatoxin 2e in a piglet producing farm with problems of Oedema disease: case study
title_full_unstemmed Implementation of a vaccine against Shigatoxin 2e in a piglet producing farm with problems of Oedema disease: case study
title_short Implementation of a vaccine against Shigatoxin 2e in a piglet producing farm with problems of Oedema disease: case study
title_sort implementation of a vaccine against shigatoxin 2e in a piglet producing farm with problems of oedema disease: case study
topic Case Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5375124/
https://www.ncbi.nlm.nih.gov/pubmed/28405415
http://dx.doi.org/10.1186/2055-5660-1-6
work_keys_str_mv AT frickeregine implementationofavaccineagainstshigatoxin2einapigletproducingfarmwithproblemsofoedemadiseasecasestudy
AT bastertolaf implementationofavaccineagainstshigatoxin2einapigletproducingfarmwithproblemsofoedemadiseasecasestudy
AT gotterverena implementationofavaccineagainstshigatoxin2einapigletproducingfarmwithproblemsofoedemadiseasecasestudy
AT bronsnico implementationofavaccineagainstshigatoxin2einapigletproducingfarmwithproblemsofoedemadiseasecasestudy
AT kampjohan implementationofavaccineagainstshigatoxin2einapigletproducingfarmwithproblemsofoedemadiseasecasestudy
AT selbitzhansjoachim implementationofavaccineagainstshigatoxin2einapigletproducingfarmwithproblemsofoedemadiseasecasestudy